WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Robert F. Kornegay
Senior Of Counsel
Corporate
San Diego
rkornegay@wsgr.com

D650-320-4533

Download vCard
Open PDF
  • Experienced Corporate Attorney

    Rob has represented tech, life sciences, and other emerging growth companies throughout the U.S. and internationally for over 25 years at Wilson Sonsini.

  • Thought Leadership

    Rob serves as a lecturer in law and venture capital finance at University of California, Hastings College of Law, and Santa Clara University School of Law.

Rob Kornegay is Senior Of Counsel with the firm, having joined Wilson Sonsini in 1994 and served as a partner from 2001 through 2025. His practice focuses primarily on the representation of technology, life science, and other emerging growth companies throughout the United States and internationally. These companies range from start-ups to large public companies as well as sources of capital for such companies. Specifically, Rob represents:

  • Public and private companies in merger and acquisition transactions;
  • Issuers, investors, and underwriters in public and private financings; and
  • Public and private companies with respect to corporate governance matters related to strategic transactions and special situations, as well as in ongoing corporate and securities law matters.

Representative recent clients and engagements include:

  • Corporate, securities, and governance representation of numerous public and private issuers, including Occam Networks, MaxLinear, Mindspeed, Fluidigm, Copart, 3Par, DisplayLink, ClairMail, and Real Networks
  • Issuer-side public offerings by various issuers, including MaxLinear, 3Par, Occam Networks, Copart, Turnstone Systems, Inktomi, and Oncothyreon
  • Financing transactions on behalf of numerous venture-capital-backed issuers, including Fluidigm, MaxLinear, Occam Networks, Silicon Optix, DisplayLink, ClairMail, and Bloom Energy
  • Acquisitions, dispositions, and other strategic transactions by numerous public and private companies, including Mindspeed, Transcept Pharmaceuticals, PC-Tel, Copart, Occam Networks, and Silicon Optix
Experience

Rob Kornegay is Senior Of Counsel with the firm, having joined Wilson Sonsini in 1994 and served as a partner from 2001 through 2025. His practice focuses primarily on the representation of technology, life science, and other emerging growth companies throughout the United States and internationally. These companies range from start-ups to large public companies as well as sources of capital for such companies. Specifically, Rob represents:

  • Public and private companies in merger and acquisition transactions;
  • Issuers, investors, and underwriters in public and private financings; and
  • Public and private companies with respect to corporate governance matters related to strategic transactions and special situations, as well as in ongoing corporate and securities law matters.

Representative recent clients and engagements include:

  • Corporate, securities, and governance representation of numerous public and private issuers, including Occam Networks, MaxLinear, Mindspeed, Fluidigm, Copart, 3Par, DisplayLink, ClairMail, and Real Networks
  • Issuer-side public offerings by various issuers, including MaxLinear, 3Par, Occam Networks, Copart, Turnstone Systems, Inktomi, and Oncothyreon
  • Financing transactions on behalf of numerous venture-capital-backed issuers, including Fluidigm, MaxLinear, Occam Networks, Silicon Optix, DisplayLink, ClairMail, and Bloom Energy
  • Acquisitions, dispositions, and other strategic transactions by numerous public and private companies, including Mindspeed, Transcept Pharmaceuticals, PC-Tel, Copart, Occam Networks, and Silicon Optix
Education
  • J.D., UCLA School of Law, 1993Comment Editor, UCLA Law Review
  • M.B.A., (Specialization in Finance), University of Chicago Graduate School of Business, 1989
  • A.B., Georgetown University, 1987
Admissions
  • State Bar of California
Credentials
Education
  • J.D., UCLA School of Law, 1993Comment Editor, UCLA Law Review
  • M.B.A., (Specialization in Finance), University of Chicago Graduate School of Business, 1989
  • A.B., Georgetown University, 1987
Admissions
  • State Bar of California

Select Speaking Engagements

  • Lecturer in Law, Venture Capital Finance
    • University of California, Hastings College of Law
    • Santa Clara University School of Law
Insights

Select Speaking Engagements

  • Lecturer in Law, Venture Capital Finance
    • University of California, Hastings College of Law
    • Santa Clara University School of Law
Focus Areas
  • Biotech
  • Capital Markets
  • Communications and Networking
  • Corporate
  • Corporate Governance
  • Data Storage and Cloud
  • Life Sciences
  • Mergers & Acquisitions
  • Semiconductors
Recent Insights
News Articles
IFLR1000 Recognizes Wilson Sonsini Practices, Attorneys in 2024 Guide
In the 2024 edition of its annual guide, IFLR recognized Wilson Sonsini practices and attorneys for their work in the financial and corporate sectors in the U.S. and China. The guide uses in-depth market analysis and interviews with practitioners and clients to determine leading financial and corporate law firms worldwide. Wilson Sonsini’s rankings are summarized below.
Learn More
Client Highlights
Wilson Sonsini Advises Iambic Therapeutics on $50 Million Series B Extension, Bringing Total Series B Funding to Over $150 Million
On June 18, 2024, Iambic Therapeutics (Iambic), a clinical-stage biotechnology company developing novel therapeutics from its unique generative AI discovery platform, announced the closing of an oversubscribed $50 million extension, bringing the total Series B funding to over $150 million. The Series B extension was led by new investors Mubadala Capital and Exor Ventures, and existing investors Abingworth, Illumina Ventures, Nexus Venture Partners, Coatue, and Tao Capital Partners. Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.